Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Minasian

Showing results (151-160 of 174) with videos related to

Pageof 18
Sort By:
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 23, 2013
Cognitive interviewing of the US National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)Jennifer L Hay, Thomas M Atkinson, Bryce B Reeve, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 30, 2019
Randomized Double-Blind Placebo-Controlled Biomarker Modulation Study of Vitamin D Supplementation in Premenopausal Women at High Risk for Breast Cancer (SWOG S0812)Katherine D Crew, Garnet L Anderson, Dawn L Hershman, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 8, 2011
Phase III trial of selenium to prevent prostate cancer in men with high-grade prostatic intraepithelial neoplasia: SWOG S9917James R Marshall, Catherine M Tangen, Wael A Sakr, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 17, 2014
Factors associated with adherence to an end-of-study biopsy: lessons from the prostate cancer prevention trial (SWOG-Coordinated Intergroup Study S9217)Ellen R Gritz, Kathryn B Arnold, Carol M Moinpour, et al.
Journal of the National Cancer Institute|January 7, 2026
Performance of multiple multi-cancer detection tests using a large independent reference set (Alliance A212102)Marie Wood, Paul F Pinsky, Paul Novotny, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 12, 2018
Feasibility of Implementing the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events in a Multicenter Trial: NCCTG N1048Ethan Basch, Amylou C Dueck, Lauren J Rogak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2020
Patient-Reported Cognitive Impairment Among Women With Early Breast Cancer Randomly Assigned to Endocrine Therapy Alone Versus Chemoendocrine Therapy: Results From TAILORxLynne I Wagner, Robert J Gray, Joseph A Sparano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2015
Recommendations for Obesity Clinical Trials in Cancer Survivors: American Society of Clinical Oncology StatementJennifer A Ligibel, Catherine M Alfano, Dawn Hershman, et al.
International Journal of Radiation Oncology, Biology, Physics|May 3, 2017
Feasibility of Patient Reporting of Symptomatic Adverse Events via the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in a Chemoradiotherapy Cooperative Group Multicenter Clinical TrialEthan Basch, Stephanie L Pugh, Amylou C Dueck, et al.
JAMA|October 13, 2011
Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)Eric A Klein, Ian M Thompson, Catherine M Tangen, et al.
Pageof 18

Showing results (151-160 of 174) with videos related to

Sort By:
Pageof 18
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 23, 2013
Cognitive interviewing of the US National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)Jennifer L Hay, Thomas M Atkinson, Bryce B Reeve, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 30, 2019
Randomized Double-Blind Placebo-Controlled Biomarker Modulation Study of Vitamin D Supplementation in Premenopausal Women at High Risk for Breast Cancer (SWOG S0812)Katherine D Crew, Garnet L Anderson, Dawn L Hershman, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 8, 2011
Phase III trial of selenium to prevent prostate cancer in men with high-grade prostatic intraepithelial neoplasia: SWOG S9917James R Marshall, Catherine M Tangen, Wael A Sakr, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 17, 2014
Factors associated with adherence to an end-of-study biopsy: lessons from the prostate cancer prevention trial (SWOG-Coordinated Intergroup Study S9217)Ellen R Gritz, Kathryn B Arnold, Carol M Moinpour, et al.
Journal of the National Cancer Institute|January 7, 2026
Performance of multiple multi-cancer detection tests using a large independent reference set (Alliance A212102)Marie Wood, Paul F Pinsky, Paul Novotny, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 12, 2018
Feasibility of Implementing the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events in a Multicenter Trial: NCCTG N1048Ethan Basch, Amylou C Dueck, Lauren J Rogak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2020
Patient-Reported Cognitive Impairment Among Women With Early Breast Cancer Randomly Assigned to Endocrine Therapy Alone Versus Chemoendocrine Therapy: Results From TAILORxLynne I Wagner, Robert J Gray, Joseph A Sparano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2015
Recommendations for Obesity Clinical Trials in Cancer Survivors: American Society of Clinical Oncology StatementJennifer A Ligibel, Catherine M Alfano, Dawn Hershman, et al.
International Journal of Radiation Oncology, Biology, Physics|May 3, 2017
Feasibility of Patient Reporting of Symptomatic Adverse Events via the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in a Chemoradiotherapy Cooperative Group Multicenter Clinical TrialEthan Basch, Stephanie L Pugh, Amylou C Dueck, et al.
JAMA|October 13, 2011
Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)Eric A Klein, Ian M Thompson, Catherine M Tangen, et al.
Pageof 18